The president will request $1.2 billion to combat and prevent antibiotic resistance in his fiscal year 2016 budget proposal, the White House announced today. The request includes more than $650 million for the National Institutes of Health and Biomedical Advanced Research and Development Authority to invest in antibacterial and rapid diagnostics and launch a large-scale effort to characterize drug resistance. (Earlier this year, NIH-supported scientists developed a novel technique for extracting antibiotics from soil.) Among other funding, the request includes $280 million to support antibiotic stewardship, resistance and outbreak monitoring, and research and development at the Centers for Disease Control and Prevention; $160 million for the departments of Veterans Affairs and Defense to address antibiotic resistance in health care settings; and $47 million for the Food and Drug Administration to evaluate new antibacterial treatments for patients and antibiotic stewardship in animal agriculture. The president is expected to release his full FY 2016 budget request on Monday.  

Related News Articles

Headline
In clinical trials involving 220,000 patients at 59 HCA Healthcare hospitals, algorithm-driven computerized alerts helped clinicians better identify the…
Headline
After declining in recent years, antimicrobial-resistant infections starting during hospitalization grew 15% from 2019 to 2020, the Centers for Disease Control…
Headline
The Centers for Disease Control and Prevention today updated its Core Elements for Hospital Antibiotic Stewardship Programs to reflect experience and evidence…
Headline
Antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths in the United States each year, according to a report released…
Headline
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA,…
Headline
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia. The antibiotic, Xenleta…